Annual report pursuant to Section 13 and 15(d)

SEGMENT REPORTING (Tables)

v3.22.1
SEGMENT REPORTING (Tables)
12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]

Information concerning the operations of the Company’s reportable segments is as follows:

 

   

2021

   

2020

 

Revenues (from external customers)

               

BioSig

  $ 441     $ -  

ViralClear

    -       -  

NeuroClear

    -       -  
    $ 441     $ -  
                 

Operating Expenses

               

BioSig

  $ 30,016     $ 30,756  

ViralClear

    3,630       28,387  

NeuroClear

    7       41  
    $ 33,653     $ 59,184  
                 

Income (loss) from operations

               

BioSig

  $ (29,772 )   $ (30,727 )

ViralClear

    (3,077 )     (28,372 )

NeuroClear

    (7 )     (41 )
    $ (32,856 )   $ (59,140 )
                 

Total Assets

               

BioSig

  $ 13,595     $ 24,764  

ViralClear

    1,924       5,622  

NeuroClear

    -       -  
    $ 15,519     $ 30,386